13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001835943
Total reported value
$1.6B
$1.6B
36 檔
8.8%
At the close of Q4 2024, AIGH Capital Management LLC disclosed equity holdings valued at approximately $1.6B, spread across 36 reported holdings.
AIGH Capital Management LLC executed strategic sector rebalancing during Q4 2024, establishing 7 new positions while fully exiting 10 holdings and trimming 7 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRVL | Marvell Technology Inc | Stock-Tech | 12.09% | — | — | |
| 2 | GLW | Corning Inc | Stock-Tech | 11.14% | — | -16.67% | |
| 3 | PSNL | Personalis Inc | Stock-Other | 6.87% | -1.07% | -5.00% | |
| 4 | MYO | Myomo Inc | Stock-Other | 6.81% | — | +21.69% | |
| 5 | ARQ | Arq Inc | Stock-Other | 6.67% | — | — | |
| 6 | DCTH | Delcath Systems Inc | Stock-Other | 5.22% | — | -22.28% | |
| 7 | SCPH | Scpharmaceuticals Inc | Stock-Other | 4.62% | — | +1.21% | |
| 8 | VSTM | Verastem Inc | Stock-Other | 4.31% | -0.99% | — | |
| 9 | LPTH | Lightpath Technologies Inc-a | Stock-Other | 4.11% | -0.14% | EXIT | |
| 10 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 3.89% | — | +9.93% | |
| 11 | ELUT | Elutia Inc | Stock-Other | 3.60% | -0.34% | +22.48% | |
| 12 | BLZE | Backblaze Inc-a | Stock-Other | 3.39% | — | — | |
| 13 | ✓ | Biodesix Inc | Stock-Other | 2.96% | — | +8.80% | |
| 14 | BKTI | Bk Technologies CORP | Stock-Other | 2.88% | -0.33% | EXIT | |
| 15 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 2.73% | — | +17.81% | |
| 16 | TELA | Tela Bio Inc | Stock-Other | 2.51% | — | +7.83% | |
| 17 | COYA | Coya Therapeutics Inc | Stock-Other | 2.15% | -0.29% | +84.96% | |
| 18 | ZVRA | Zevra Therapeutics Inc | Stock-Other | 2.06% | -1.53% | EXIT | |
| 19 | ELVA | Electrovaya Inc | Stock-Other | 1.96% | — | +3.17% | |
| 20 | IPWR | Ideal Power Inc | Stock-Other | 1.94% | -0.16% | +17.62% | |
| 21 | TQ80 | Theratechnologies Inc | Stock-Other | 1.71% | — | -18.75% | |
| 22 | IDN | Intellicheck Inc | Stock-Other | 1.42% | -1.45% | EXIT | |
| 23 | ✓ | Polypid LTD | Stock-Other | 0.78% | -0.47% | +21.80% | |
| 24 | GRCE | Grace Therapeutics Inc | Stock-Other | 0.61% | — | — | |
| 25 | FKWL | Franklin Wireless CORP | Stock-Other | 0.60% | — | — | |
| 26 | APRE | Aprea Therapeutics Inc | Stock-Other | 0.55% | -0.06% | — | |
| 27 | INABEUR | In8bio Inc | Stock-Other | 0.50% | — | +269.74% | |
| 28 | INO | Inovio Pharmaceuticals Inc | Stock-Other | 0.37% | — | — | |
| 29 | BFRI | Biofrontera Inc | Stock-Other | 0.28% | -0.06% | +61.76% | |
| 30 | KPRX | Kiora Pharmaceuticals Inc | Stock-Other | 0.27% | — | — | |
| 31 | KALAEUR | Kala Bio Inc | Stock-Other | 0.26% | — | — | |
| 32 | CYTXEUR | Plus Therapeutics Inc | Stock-Other | 0.20% | — | — | |
| 33 | ✓ | Stock-Other | 0.20% | — | — | ||
| 34 | SMTK | Smartkem Inc | Stock-Other | 0.14% | -0.03% | EXIT | |
| 35 | ✓ | Beyond Air Inc | Stock-Other | 0.11% | — | -72.48% | |
| 36 | MCHX | Marchex Inc-class B | Stock-Other | 0.11% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MRVL | Marvell Technology Inc | +12.1% | NEW | New buy |
| 2 | VSTM | Verastem Inc | +4.3% | NEW | New buy |
| 3 | MYO | Myomo Inc | +3.7% | +21.69% | Add |
| 4 | BLZE | Backblaze Inc-a | +3.4% | NEW | New buy |
| 5 | LPTH | Lightpath Technologies Inc-a | +2.7% | — | Unchanged |
| 6 | ZVRA | Zevra Therapeutics Inc | +2.1% | NEW | New buy |
| 7 | ARQ | Arq Inc | +2% | — | Unchanged |
| 8 | TARS | Tarsus Pharmaceuticals Inc | +2% | +9.93% | Add |
| 9 | BKTI | Bk Technologies CORP | +1.1% | -5.16% | Trim |
| 10 | COYA | Coya Therapeutics Inc | +1% | +84.96% | Add |
| 11 | XERS | Xeris Biopharma Holdings Inc | +1% | +17.81% | Add |
| 12 | ELUT | Elutia Inc | +0.9% | +22.48% | Add |
| 13 | PSNL | Personalis Inc | +0.8% | -5.00% | Trim |
| 14 | TELA | Tela Bio Inc | +0.8% | +7.83% | Add |
| 15 | DCTH | Delcath Systems Inc | +0.7% | -22.28% | Trim |
| 16 | GRCE | Grace Therapeutics Inc | +0.6% | NEW | New buy |
| 17 | TQ80 | Theratechnologies Inc | +0.4% | -18.75% | Trim |
| 18 | INO | Inovio Pharmaceuticals Inc | +0.4% | NEW | New buy |
| 19 | INABEUR | In8bio Inc | +0.4% | +269.74% | Add |
| 20 | ELVA | Electrovaya Inc | +0.4% | +3.17% | Add |
| 21 | IDN | Intellicheck Inc | +0.3% | -8.49% | Trim |
| 22 | IPWR | Ideal Power Inc | +0.3% | +17.62% | Add |
| 23 | KALAEUR | Kala Bio Inc | +0.3% | NEW | New buy |
| 24 | APRE | Aprea Therapeutics Inc | +0.1% | — | Unchanged |
| 25 | ✓ | Biodesix Inc | +0.1% | +8.80% | Add |
| 26 | ✓ | Polypid LTD | +0.1% | +21.80% | Add |
| 27 | FKWL | Franklin Wireless CORP | +0.1% | — | Unchanged |
| 28 | BFRI | Biofrontera Inc | +0.1% | +61.76% | Add |
| 29 | KPRX | Kiora Pharmaceuticals Inc | 0% | — | Unchanged |
| 30 | MCHX | Marchex Inc-class B | 0% | — | Unchanged |
| 31 | SVREW | Saverone 2014 LTD -cw27 | 0% | EXIT | Sold out |
| 32 | SMTK | Smartkem Inc | 0% | +16.19% | Add |
| 33 | CYTXEUR | Plus Therapeutics Inc | 0% | — | Unchanged |
| 34 | ✓ | -0.1% | — | Unchanged | |
| 35 | EVOK | Evoke Pharma Inc | -0.1% | EXIT | Sold out |
| 36 | ✓ | Beyond Air Inc | -0.3% | -72.48% | Trim |
| 37 | GLW | Corning Inc | -0.3% | -16.67% | Trim |
| 38 | IMMX | Immix Biopharma Inc | -0.5% | EXIT | Sold out |
| 39 | ✓ | -0.5% | EXIT | Sold out | |
| 40 | MX | Magnachip Semiconductor CORP | -0.6% | EXIT | Sold out |
| 41 | MRAM | Everspin Technologies Inc | -0.6% | EXIT | Sold out |
| 42 | SCPH | Scpharmaceuticals Inc | -0.7% | +1.21% | Add |
| 43 | EGRX | Eagle Pharmaceuticals Inc | -1.3% | EXIT | Sold out |
| 44 | CLRBUSD | Cellectar Biosciences Inc | -1.9% | EXIT | Sold out |
| 45 | APPS | Digital Turbine Inc | -3.9% | EXIT | Sold out |
| 46 | XBI | Ss Spdr S&p Biotech ETF | -31.2% | EXIT | Sold out |
According to official SEC Form 13F filings, AIGH Capital Management LLC reported a total U.S. public equity portfolio value of $1.6B across 36 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MRVL, GLW, PSNL) accounted for 8.8% of total reported equity market value during Q4 2024.
Top New Position Initiated
MRVL
市值: $38.7M
Top Position Liquidated / Trimmed
XBI
前期市值: $110.4M
During Q4 2024, AIGH Capital Management LLC's top holdings by market value included MRVL (12.1%)、GLW (11.1%)、PSNL (6.9%). The largest single position, MRVL, represented 12.1% of total portfolio value.
In Q4 2024, AIGH Capital Management LLC made 38 total portfolio adjustments, initiating 7 new buys, adding to 14 positions, trimming 7 holdings, and fully liquidating 10 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.